Filing Details
- Accession Number:
- 0000849146-23-000153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-26 16:06:40
- Reporting Period:
- 2023-09-22
- Accepted Time:
- 2023-09-26 16:06:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
849146 | Lifevantage Corp | LFVN | Pharmaceutical Preparations (2834) | 900224471 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1698767 | Darwin Lewis | 3300 Triumph Blvd, Suite 700 Lehi UT 84043 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-09-22 | 4,124 | $6.94 | 89,408 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected by an automatic purchase pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2023.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.77 to $6.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.